Witnessing the stock’s movement on the chart, on Wednesday, Disc Medicine Inc (NASDAQ: IRON) set off with pace as it heaved 12.89% to $38.70, before settling in for the price of $34.28 at the close. Taking a more long-term approach, IRON posted a 52-week range of $25.64-$68.73.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was 38.12%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -21.89%. This publicly-traded company’s shares outstanding now amounts to $29.87 million, simultaneously with a float of $21.83 million. The organization now has a market capitalization sitting at $1.34 billion. At the time of writing, stock’s 50-day Moving Average stood at $52.39, while the 200-day Moving Average is $52.80.
Disc Medicine Inc (IRON) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Disc Medicine Inc’s current insider ownership accounts for 36.84%, in contrast to 51.72% institutional ownership. According to the most recent insider trade that took place on Mar 24 ’25, this organization’s Director sold 5,738 shares at the rate of 54.11, making the entire transaction reach 310,483 in total value, affecting insider ownership by 186,541. Preceding that transaction, on Mar 24 ’25, Company’s Director sold 5,738 for 54.11, making the whole transaction’s value amount to 310,483. This particular insider is now the holder of 186,541 in total.
Disc Medicine Inc (IRON) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.17 per share during the current fiscal year.
Disc Medicine Inc’s EPS decrease for this current 12-month fiscal period is -21.89% and is forecasted to reach -5.28 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -1.67% through the next 5 years, which can be compared against the 38.12% growth it accomplished over the previous five years trading on the market.
Disc Medicine Inc (NASDAQ: IRON) Trading Performance Indicators
Let’s observe the current performance indicators for Disc Medicine Inc (IRON). It’s Quick Ratio in the last reported quarter now stands at 21.17. The Stock has managed to achieve an average true range (ATR) of 3.80.
In the same vein, IRON’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.99, a figure that is expected to reach -1.11 in the next quarter, and analysts are predicting that it will be -5.28 at the market close of one year from today.
Technical Analysis of Disc Medicine Inc (IRON)
Going through the that latest performance of [Disc Medicine Inc, IRON]. Its last 5-days volume of 0.99 million indicated improvement to the volume of 0.44 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 16.76% While, its Average True Range was 4.54.
Raw Stochastic average of Disc Medicine Inc (IRON) in the period of the previous 100 days is set at 21.00%, which indicates a major fall in contrast to 33.15% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 93.88% that was higher than 50.35% volatility it exhibited in the past 100-days period.
